CAS: 1135205-94-5
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | AWL-II-38.3 REF: 54-BUP07458CAS: 1135205-94-5 | 99.87% | 812,00 €~2.932,00 € | Do 17 Apr 25 |
 | AWL-II-38.3 REF: TM-T38511CAS: 1135205-94-5 | 99.87% - 99.87% | 81,00 €~2.167,00 € | Do 17 Apr 25 |
Ref: 54-BUP07458
| 25mg | 812,00 € | ||
| 50mg | 1.145,00 € | ||
| 100mg | 1.454,00 € | ||
| 500mg | 2.932,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 17. April 2025
AWL-II-38.3
CAS:1135205-94-5
AWL-II-38.3 is a highly potent EphA3 inhibitor with potent kinase inhibitory activity against EphA3.Cost-effective and …
Formel:
C23H18F3N5O3
Reinheit:
99.87% - 99.87%
Farbe und Form:
Liquid
Molekulargewicht:
469.42
Ref: TM-T38511
| 1mg | 81,00 € | ||
| 5mg | 170,00 € | ||
| 10mg | 264,00 € | ||
| 25mg | 543,00 € | ||
| 50mg | 780,00 € | ||
| 100mg | 1.074,00 € | ||
| 500mg | 2.167,00 € | ||
| 1mL*10mM (DMSO) | 177,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 17. April 2025
